AXIM BIOTECH is a company that pursues cannabinoid research and product development. The company also has developed several nutraceutical products, primarily based around chewing gum. What is AXIM BIOTECH? One of the biggest issues that plagues the legalization of cannabis has been the lack of data on the substance. While … AXIM® Biotech Enters IBS Clinical Trial for CanChew CBD Chewing NEW YORK, Jan. 18, 2017 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (AXIM ® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, entered a clinical trial on treating irritable bowel syndrome (IBS) with the company’s CanChew Plus® CBD gum at Wageningen University in the Netherlands. AXIM to Launch CBD Chewing Gum to Treat Chemotherapy Symptoms - CBD-Based Chewing Gum. In the coming months, AXIM plans to conduct a bioequivalence study between its chewing gum with dronabinol and FDA-approved capsules containing dronabinol. The company intends to later provide evidence that the dronabinol chewing gum can serve as an alternative to orally ingested dronabinol for the treatment of symptoms AXIM Looks to Help Chemotherapy Effects via CBD Chewing Gum with
AXIM Biotech Begins PK/PD Studies With CanChew Plus CBD Gum for
AXIM Biotechnologies, Inc. has started manufacturing its cannabinoid-based chewing gum with dronabinol, a synthetic THC form. The announcement was made Feb 13, 2019 AXIM Biotechnologies Inc (OTCQB: AXIM) CEO John Huemoeller tells AXIM Biotechnologies receives purchase order on its CBD gum, May 14, 2019 In April, AXIM entered into a service agreement with QPS Netherlands BV to conduct research on chewing gum infused with THC and CBD. Feb 13, 2019 AXIM Biotechnologies Inc (OTCQB: AXIM) CEO John Huemoeller tells AXIM Biotechnologies receives purchase order on its CBD gum, Feb 14, 2019 Subsidiary Kannaway® Places Significant Initial Purchase Order for Major Investment Company AXIM® Biotechnologies CBD Chewing Gum Alternative Names: CanChew®Rx; CanChew® RL; CBD/THC gum; MedChew Axim Biotech uses unique extraction and purification methods, developed in Chewing Gum with all cannabinoids. US Patent Ophthalmic solutions with THC, CBD and CBG Using Axim's patented CBD toothpaste and mouthwash.
AXIM Biotech Begins PK/PD Studies With CanChew Plus CBD Gum for
AXIM® Biotech Enters IBS Clinical Trial for CanChew CBD Chewing NEW YORK, Jan. 18, 2017 (GLOBE NEWSWIRE) -- AXIM ® Biotechnologies, Inc. (AXIM ® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, entered a clinical trial on treating irritable bowel syndrome (IBS) with the company’s CanChew Plus® CBD gum at Wageningen University in the Netherlands. AXIM to Launch CBD Chewing Gum to Treat Chemotherapy Symptoms - CBD-Based Chewing Gum. In the coming months, AXIM plans to conduct a bioequivalence study between its chewing gum with dronabinol and FDA-approved capsules containing dronabinol. The company intends to later provide evidence that the dronabinol chewing gum can serve as an alternative to orally ingested dronabinol for the treatment of symptoms AXIM Looks to Help Chemotherapy Effects via CBD Chewing Gum with
AXIM®, a leader in hemp-based cannabinoid research and development, recently announced that the U.S. Patent and Trademark Office issued a Notice of Allowance for Patent 9,433,601 covering the use
CBD Buy CanChew Gum - The CBD Store Tinctures, Capsules, Buy CanChew Gum Buy CBD from The CBD Store. CBD Oil for Health and Wellness "The CBD Store" allows you to buy CBD online. Buy CBD Oil to be delivered in All 50 United States. CBD is an acronym for Cannabidiol. Cannabidiol is one of 85 Cannabinoids that interact with your endocannabinoid system AXIM Biotech Expands Patent Protection on Cannabinoid Chewing Gum AXIM®, a leader in hemp-based cannabinoid research and development, recently announced that the U.S. Patent and Trademark Office issued a Notice of Allowance for Patent 9,433,601 covering the use